- About us
- A new Institute dedicated to combating leukemia
- Medical-scientific program
- History of Hematology on the Saint-Louis Campus
- The Leukemia Institute’s governance
- Press
- Contact us
- Our news
- Profile of Valéria Bisio, Research Officer
- Creation of a Hemato-Oncogenetics Unit
- Profile of Alice Gros, a peer-support patient
- Winners of the Leukemia Institute’s first call for projects
- Profile of Julien Calvo, researcher
- Support us
- Join us
- You are
- Patients and relatives
- To be cared for and supported
- Become an expert patient
- Discover the Leukemia Institute
- Researchers
- Research
- Clinical trials
- Discover the Leukemia Institute
- Healthcare professionals
- Refer a patient
- Our clinical research
- Discover the Leukemia Institute
- Industry partners
- Discover the Leukemia Institute
- Translational research
- Donors
- Support us
- Discover the Leukemia Institute
- Care
- Patient care
- Being Treated at the Leukemia Institute
- Cancer treatments
- Supportive Care
- Open Multidisciplinary Meetings
- Our clinical services
- Saint-Louis Hospital – Department of adult hematology
- Saint-Louis Hospital – Hematology Transplant Unit
- Saint-Louis Hospital – Department of Pharmacology and Clinical Investigations
- Saint-Louis Hospital – Adolescent and Young Adult Unit
- Saint-Louis Hospital – Outpatient Hemato-oncogenetics Unit
- Saint-Louis Hospital – Department of senior hematology
- Robert-Debré Hospital – Department of pediatric hematology and immunology
- Necker Hospital – Department of Adult Hematology
- Cochin–Port Royal Hospital – Department of clinical hematology
- Avicenne Hospital – Department of clinical hematology and cell therapy
- Our medical laboratories
- Hematology Medical Laboratory, Michaela Fontenay
- Hematology Medical Laboratory, Jean Soulier
- Molecular Genetics Unit, Hélène Cavé
- Hematology Medical Laboratory, Vahid Asnafi
- Patient information
- Acute Myeloid Leukemias
- Acute Lymphoblastic Leukemias
- Myeloproliferative Neoplasms
- Myelodysplastic Syndrome
- Cancer treatments
- Supportive Care
- Psychological Support
- Research
- Our research teams
- Hugues de Thé’s team – Molecular pathology
- Raphaël Itzykson’s team – Functional precision medicine for leukemia
- Michaela Fontenay’s team – Normal and pathological hematopoiesis
- Françoise Pflumio’s team – Niche, Cancer, and Radiation in Hematopoiesis
- Sylvie Méléard’s team – Population Evolution and Interaction Particle Systems
- David Michonneau’s team – Translational Immunology in Immunotherapy and Hematology (TIGITH)
- Lina Benajiba’s team – Identification and targeting of extrinsic regulators of myeloid malignancies
- Karl Balabanian’s team – Lymphoid niches, Chemokines and Immuno-hematological syndromes
- Alexandre Puissant’s team – Molecular Mechanisms of Acute Myeloid Leukemia Development
- Stéphane Giraudier’s team – Chronic Myeloid Malignancies, Microenvironment & Translational Research
- Diana Passaro’s team – Leukemia & Niche Dynamics
- Camille Lobry’s team – Genetic and Epigenetic control of Normal and Malignant Hematopoiesis
- Jean Soulier’s team – Stem cell dysfunction and secondary AML
- Sylvie Chevret’s team – Biostatistics and clinical epidemiology
- Our technological platforms
- Our clinical research
A new institute
dedicated to combating leukemia
The diseases we treat
Leukemia predisposition syndromes
Acquired and congenital bone marrow failure
Leukemia predisposition syndromes
Acquired and congenital bone marrow failure
The Leukemia Institute: key figures
1stleukemia treatment and research center in France
Research teams
14Clinical departments
80Ongoing clinical trials
Our 4 areas of expertise
Innovation
Innovative patents and industrial collaborations, including through our drug screening platform
Our news
ResearchersProfile of Vincent Bansaye, Professor at École Polytechnique in “Population Evolution and Interaction Particle Systems” team led by Sylvie Méléard
Read the articlePatientsExceptional Leukemia Institute launch concert
Read the articleIndustry partnersSecond edition of LEUKEMIA 360
Read the articleHealthcare professionalsCreation of a Hemato-Oncogenetics Unit led by Professor Marie Sébert
Read the articleOur featured research projects
Intrinsic and extrinsic effects of the immune microenvironment in myelodysplastic syndromes
This project employs in vitro and ex vivo models to decipher how stromal and blast cells alter bone marrow NK cell-mediated immunosurveillance during MDS initiation and progression.
Nicolas Dulphy / Valéria Bisio
E-selectin antagonists in leukemia
Evaluation of molecules to block leukemia-microenvironment interaction and restore chemosensitivity.
Julien Calvo
Targeting the myeloid-specific isoform PIK3CG using heterobifunctional PROTAC-type degrader molecules to block AML progression.
Lois Kelly
Host foundation and founding members
Stay up to date by subscribing to the institute's newsletter
- Discover the Leukemia Institute
- Translational research
- Our clinical research
- Clinical trials
- Become an expert patient
- To be cared for and supported
- A new Institute dedicated to combating leukemia